Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001493152-26-015592

Options or other derivatives

  • Chief Clinical Officer acquired 128,550 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Gentry Leesa Chief Clinical Officer 2026-04-03 Grant or award · Stock Option +128,550 128,550 D
Loading xslF345X06/ownership.xml…